This study examines the use of cryoablation as an alternative to surgery in the treatment
of early stage invasive breast cancer. The hypothesis is that cryoablation will complete
ablation and destroy the tumor in a selected population of women who may otherwise be
adequately treated with surgery.
Additional locations may be listed on ClinicalTrials.gov for NCT01992250.
See trial information on ClinicalTrials.gov for a list of participating sites.
PURPOSE:
To determine the rate of successful tumor ablation in patients treated with cryoablation
and endocrine therapy in a subset of patients with early stage breast cancer.
OUTLINE:
1. Core Biopsy (Pre-Registration)
2. Magnetic Resonance Imaging (Pre-Registration)
3. Tumor Cryoablation
4. Core Biopsy (Post-Cryoablation)
5. Magnetic Resonance Imaging (Post-Cryoablation)
6. Postoperative Follow-up
7. Evaluation of outcomes
Trial PhaseNo phase specified
Trial Typetreatment
Lead OrganizationSanarus Technologies, Inc.
